calcium chloride 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4201	10043-52-4

Description:

Molecule	Description
Synonyms: calcium chloride	A salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning. Molecular weight: 110.98 Formula: CaCl2 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: ALOGS: ROTB: None

Molecule

Description

Synonyms:

calcium chloride

A salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning.

Molecular weight: 110.98
Formula: CaCl2
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA:
ALOGS:
ROTB: None

Drug dosage:

Dose	Unit	Route
0.20	g	P

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
March 22, 1971	FDA	BAXTER HLTHCARE

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Death	628.11	18.66	461	7244	324918	50272501
Peritonitis bacterial	512.77	18.66	123	7582	4538	50592881
Peritonitis	358.78	18.66	121	7584	15365	50582054
Peritoneal dialysis complication	330.15	18.66	67	7638	1114	50596305
Toxic anterior segment syndrome	322.67	18.66	69	7636	1496	50595923
Fungal peritonitis	217.28	18.66	41	7664	456	50596963
Device interaction	160.36	18.66	28	7677	193	50597226
Sepsis	146.13	18.66	137	7568	132788	50464631
Endophthalmitis	127.18	18.66	37	7668	2879	50594540
Encapsulating peritoneal sclerosis	87.50	18.66	18	7687	320	50597099
Ultrafiltration failure	84.12	18.66	16	7689	186	50597233
Hypotension	70.02	18.66	127	7578	235342	50362077
Cardiac arrest	69.19	18.66	74	7631	83577	50513842
Fear	66.66	18.66	36	7669	14513	50582906
Peritoneal cloudy effluent	62.84	18.66	11	7694	77	50597342
Renal injury	62.16	18.66	29	7676	8582	50588837
Post procedural complication	57.26	18.66	33	7672	15071	50582348
Renal ischaemia	51.95	18.66	13	7692	569	50596850
Hypervolaemia	50.37	18.66	37	7668	25462	50571957
Cardiac disorder	50.35	18.66	46	7659	42933	50554486
Diabetes insipidus	48.91	18.66	17	7688	2347	50595072
Cardiovascular disorder	48.26	18.66	26	7679	10428	50586991
Anhedonia	47.67	18.66	25	7680	9499	50587920
Anterior chamber inflammation	44.18	18.66	10	7695	283	50597136
PCO2 increased	43.26	18.66	13	7692	1130	50596289
Unevaluable event	40.26	18.66	42	7663	46024	50551395
Bloody peritoneal effluent	40.11	18.66	7	7698	48	50597371
Myocardial infarction	40.00	18.66	58	7647	88969	50508450
Fatigue	39.78	18.66	30	7675	707571	49889848
PO2 increased	38.37	18.66	11	7694	811	50596608
Cardiac failure	37.80	18.66	52	7653	75988	50521431
Gangrene	37.61	18.66	17	7688	4675	50592744
Blood pH decreased	37.11	18.66	14	7691	2441	50594978
Injury	36.45	18.66	41	7664	48884	50548535
Cerebrovascular accident	35.89	18.66	57	7648	94623	50502796
Multiple organ dysfunction syndrome	35.49	18.66	41	7664	50296	50547123
Marasmus	35.18	18.66	9	7696	431	50596988
Cataract operation complication	34.49	18.66	7	7698	116	50597303
Arthralgia	34.39	18.66	12	7693	438690	50158729
Clonus	33.07	18.66	15	7690	4160	50593259
Oxygen saturation abnormal	32.31	18.66	13	7692	2689	50594730
Emotional distress	32.24	18.66	30	7675	28633	50568786
Blood bicarbonate decreased	32.21	18.66	13	7692	2712	50594707
Renal failure	32.20	18.66	58	7647	106575	50490844
Anterior chamber disorder	30.64	18.66	6	7699	82	50597337
Electroencephalogram abnormal	29.07	18.66	13	7692	3486	50593933
Headache	29.01	18.66	21	7684	506514	50090905
Foetal death	28.70	18.66	17	7688	8163	50589256
Drug ineffective	27.59	18.66	52	7653	819281	49778138
Foetal growth restriction	26.51	18.66	15	7690	6612	50590807
Diabetic complication	25.62	18.66	8	7697	790	50596629
Infantile apnoea	24.92	18.66	8	7697	865	50596554
Joint swelling	24.48	18.66	4	7701	245282	50352137
Hypoglycaemia	24.18	18.66	35	7670	53546	50543873
Blood calcium decreased	23.92	18.66	22	7683	20684	50576735
Drug intolerance	23.19	18.66	3	7702	219101	50378318
Noninfectious peritonitis	22.24	18.66	5	7700	137	50597282
Peripheral swelling	21.37	18.66	3	7702	205933	50391486
Renal impairment	21.37	18.66	40	7665	75621	50521798
Diarrhoea	20.96	18.66	36	7669	588440	50008979
Rheumatoid arthritis	20.90	18.66	3	7702	202547	50394872
Cerebral haemorrhage	20.70	18.66	23	7682	27029	50570390
Device related sepsis	19.93	18.66	10	7695	3465	50593954
Procedural complication	19.52	18.66	11	7694	4812	50592607
Selective eating disorder	19.13	18.66	8	7697	1824	50595595
Blood pressure decreased	18.92	18.66	32	7673	55877	50541542

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Peritonitis bacterial	722.73	20.50	190	7974	5566	29560797
Death	660.62	20.50	621	7543	341463	29224900
Peritonitis	439.55	20.50	162	8002	14662	29551701
Peritoneal dialysis complication	438.04	20.50	99	8065	1498	29564865
Fungal peritonitis	308.55	20.50	64	8100	628	29565735
Toxic anterior segment syndrome	266.64	20.50	61	8103	975	29565388
Device interaction	128.52	20.50	30	8134	525	29565838
Injury	116.73	20.50	70	8094	18976	29547387
Fear	109.09	20.50	53	8111	9451	29556912
Encapsulating peritoneal sclerosis	106.50	20.50	26	8138	555	29565808
Cardiac disorder	105.14	20.50	85	8079	37178	29529185
Ultrafiltration failure	102.38	20.50	20	8144	140	29566223
Renal injury	99.68	20.50	51	8113	10151	29556212
Cardiac arrest	91.13	20.50	115	8049	85476	29480887
Myocardial infarction	86.85	20.50	128	8036	110168	29456195
Cardiac failure	85.14	20.50	107	8057	79180	29487183
Emotional distress	82.35	20.50	50	8114	13845	29552518
Gangrene	81.95	20.50	34	8130	4184	29562179
Post procedural complication	81.87	20.50	45	8119	10344	29556019
Peritoneal cloudy effluent	80.93	20.50	16	8148	120	29566243
Anhedonia	76.19	20.50	38	8126	7162	29559201
Noninfectious peritonitis	75.81	20.50	15	8149	113	29566250
Unevaluable event	75.62	20.50	64	8100	29787	29536576
Sepsis	75.01	20.50	138	8026	142544	29423819
Hypervolaemia	71.69	20.50	50	8114	17495	29548868
Endophthalmitis	65.79	20.50	26	8138	2822	29563541
Toxic epidermal necrolysis	56.70	20.50	44	8120	18109	29548254
Stress	52.21	20.50	45	8119	21445	29544918
Catheter site infection	52.06	20.50	20	8144	2012	29564351
Cardiovascular disorder	49.98	20.50	31	8133	8904	29557459
Multiple organ dysfunction syndrome	47.77	20.50	72	8092	63044	29503319
Cataract operation complication	44.53	20.50	10	8154	146	29566217
Bloody peritoneal effluent	42.76	20.50	9	8155	95	29566268
Hypotension	38.18	20.50	129	8035	194225	29372138
Peritoneal effluent abnormal	36.76	20.50	7	8157	42	29566321
Renal failure	36.01	20.50	92	8072	118507	29447856
Fatigue	32.67	20.50	24	8140	316797	29249566
Complication associated with device	31.56	20.50	19	8145	5172	29561191
Cerebrovascular accident	31.36	20.50	67	8097	76844	29489519
Blood glucose false positive	30.35	20.50	6	8158	45	29566318
Procedural pain	29.66	20.50	17	8147	4227	29562136
Hernia	27.71	20.50	21	8143	8337	29558026
Procedural complication	25.04	20.50	15	8149	4045	29562318
Peritoneal disorder	24.93	20.50	7	8157	261	29566102
Anxiety	24.62	20.50	65	8099	85300	29481063
Keratitis	24.32	20.50	10	8154	1202	29565161
Localised infection	23.99	20.50	24	8140	13792	29552571
Drug interaction	22.96	20.50	13	8151	197372	29368991
Peritoneal effluent leukocyte count increased	22.35	20.50	4	8160	16	29566347

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Peritonitis bacterial	960.53	17.68	240	11466	8803	64478223
Toxic anterior segment syndrome	519.83	17.68	114	11592	2325	64484701
Peritonitis	503.04	17.68	184	11522	24839	64462187
Peritoneal dialysis complication	451.89	17.68	100	11606	2128	64484898
Death	399.87	17.68	462	11244	482243	64004783
Fungal peritonitis	313.62	17.68	64	11642	907	64486119
Device interaction	225.37	17.68	46	11660	652	64486374
Endophthalmitis	180.16	17.68	58	11648	5307	64481719
Fear	173.75	17.68	81	11625	20090	64466936
Renal injury	161.54	17.68	71	11635	15358	64471668
Encapsulating peritoneal sclerosis	156.10	17.68	35	11671	790	64486236
Injury	134.59	17.68	98	11608	55894	64431132
Unevaluable event	134.31	17.68	94	11612	50395	64436631
Anhedonia	130.43	17.68	59	11647	13647	64473379
Cardiac arrest	118.91	17.68	143	11563	153921	64333105
Emotional distress	112.26	17.68	74	11632	35964	64451062
Sepsis	103.99	17.68	165	11541	230176	64256850
Post procedural complication	102.94	17.68	58	11648	21295	64465731
Peritoneal cloudy effluent	97.94	17.68	19	11687	204	64486822
Ultrafiltration failure	95.85	17.68	19	11687	230	64486796
Cataract operation complication	82.06	17.68	17	11689	260	64486766
Gangrene	77.53	17.68	34	11672	7304	64479722
Hypotension	75.96	17.68	194	11512	380780	64106246
Multiple organ dysfunction syndrome	73.07	17.68	91	11615	101322	64385704
Cardiac disorder	69.84	17.68	67	11639	55749	64431277
Renal failure	67.01	17.68	119	11587	181569	64305457
Noninfectious peritonitis	66.36	17.68	14	11692	235	64486791
Stress	59.89	17.68	64	11642	60470	64426556
Hypervolaemia	55.70	17.68	50	11656	38235	64448791
Blood glucose false positive	52.76	17.68	9	11697	43	64486983
Myocardial infarction	49.18	17.68	99	11607	165722	64321304
Bloody peritoneal effluent	47.91	17.68	10	11696	159	64486867
Toxic epidermal necrolysis	45.32	17.68	44	11662	37122	64449904
Complication associated with device	44.60	17.68	30	11676	15050	64471976
Fatigue	42.64	17.68	44	11662	748686	63738340
Headache	41.90	17.68	22	11684	529445	63957581
Renal ischaemia	41.70	17.68	13	11693	1070	64485956
Renal impairment	40.48	17.68	81	11625	134936	64352090
Cardiac failure	39.19	17.68	79	11627	132294	64354732
Catheter site infection	37.37	17.68	19	11687	5674	64481352
Arthralgia	37.05	17.68	17	11689	442243	64044783
Anxiety	36.98	17.68	100	11606	202549	64284477
PCO2 increased	36.20	17.68	13	11693	1654	64485372
Procedural complication	35.72	17.68	20	11686	7245	64479781
Diabetes insipidus	35.36	17.68	17	11689	4504	64482522
Peritoneal effluent abnormal	34.31	17.68	6	11700	34	64486992
PO2 increased	33.77	17.68	12	11694	1480	64485546
Anterior chamber disorder	32.11	17.68	7	11699	138	64486888
Foetal death	31.00	17.68	17	11689	5913	64481113
Peritoneal disorder	30.15	17.68	9	11697	640	64486386
Completed suicide	29.97	17.68	3	11703	224411	64262615
Hypoglycaemia	29.45	17.68	56	11650	89836	64397190
Diabetic complication	28.86	17.68	10	11696	1145	64485881
Blood pressure decreased	27.37	17.68	53	11653	86146	64400880
Blood pH decreased	26.90	17.68	14	11692	4388	64482638
Oxygen saturation abnormal	26.64	17.68	13	11693	3558	64483468
Clonus	25.29	17.68	15	11691	6052	64480974
Peripheral swelling	25.01	17.68	4	11702	209149	64277877
Drug interaction	24.50	17.68	18	11688	362065	64124961
Dizziness	23.60	17.68	26	11680	430137	64056889
Blood bicarbonate decreased	22.94	17.68	13	11693	4816	64482210
Multimorbidity	22.38	17.68	8	11698	1004	64486022
Haemodialysis	22.29	17.68	21	11685	17056	64469970
Electroencephalogram abnormal	22.04	17.68	13	11693	5190	64481836
Keratitis	21.82	17.68	11	11695	3226	64483800
Blood calcium decreased	21.77	17.68	25	11681	25529	64461497
Infusion site ischaemia	20.77	17.68	3	11703	3	64487023
Rash erythematous	20.71	17.68	34	11672	48599	64438427
Amylase abnormal	20.36	17.68	4	11702	46	64486980
Cerebrovascular accident	20.34	17.68	63	11643	137520	64349506
Alopecia	20.19	17.68	3	11703	165687	64321339
Product complaint	20.18	17.68	17	11689	11937	64475089
Peritoneal fluid analysis abnormal	19.64	17.68	4	11702	56	64486970
Corneal oedema	18.90	17.68	9	11697	2334	64484692
Product dose omission issue	18.74	17.68	6	11700	194741	64292285
Staphylococcal infection	18.38	17.68	33	11673	50645	64436381
Drug ineffective	18.01	17.68	85	11621	840162	63646864
Blood loss anaemia	17.97	17.68	17	11689	13875	64473151
Product use issue	17.91	17.68	3	11703	151712	64335314

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	A12AA07	ALIMENTARY TRACT AND METABOLISM MINERAL SUPPLEMENTS CALCIUM Calcium
ATC	B05XA07	BLOOD AND BLOOD FORMING ORGANS BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS I.V. SOLUTION ADDITIVES Electrolyte solutions
ATC	G04BA03	GENITO URINARY SYSTEM AND SEX HORMONES UROLOGICALS UROLOGICALS Acidifiers
CHEBI has role	CHEBI:33287	fertilizers

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Hypocalcemia	indication	5291005
Hyperkalemia	indication	14140009
Hypokalemia	indication	43339004
Hypermagnesemia	indication	66978005
Hypocalcemic tetany	indication	190869004
Disorder of electrolytes	indication	237840007
Cardiac arrest	indication	410429000	DOID:0060319
Surgical Hemostasis Adjunct	indication
Hypokalemia Prevention	indication
Skin Grafting Adjunct	indication
Neonatal hypocalcemic tetany	off-label use	18442000
Brain damage	contraindication	2470005
Anuria	contraindication	2472002	DOID:2983
Tachyarrhythmia	contraindication	6285003
Urinary tract obstruction	contraindication	7163005	DOID:5200
Respiratory acidosis	contraindication	12326000
Poisoning by digitalis glycoside	contraindication	12876009
Peptic ulcer	contraindication	13200003	DOID:750
Chronic obstructive lung disease	contraindication	13645005	DOID:3083
Severe chronic ulcerative colitis	contraindication	14311001
Myocardial infarction	contraindication	22298006	DOID:5844
Ventricular tachycardia	contraindication	25569003
Complete atrioventricular block	contraindication	27885002
Toxic megacolon	contraindication	28536002	DOID:1770
Atony of colon	contraindication	29479008
Sarcoidosis	contraindication	31541009	DOID:11335
Hyperthyroidism	contraindication	34486009	DOID:7998
Acute hepatitis	contraindication	37871000
Hypertensive disorder	contraindication	38341003	DOID:10763
Complete trisomy 21 syndrome	contraindication	41040004	DOID:14250
Achalasia of esophagus	contraindication	45564002	DOID:9164
End stage renal disease	contraindication	46177005	DOID:784
Humoral hypercalcemia of malignancy	contraindication	47709007
Chronic heart failure	contraindication	48447003
Bradycardia	contraindication	48867003
Acidosis	contraindication	51387008
Paralytic ileus	contraindication	55525008	DOID:8442
Heart disease	contraindication	56265001	DOID:114
Peptic reflux disease	contraindication	57643001
Congenital myotonia, autosomal dominant form	contraindication	57938005
Acute nephropathy	contraindication	58574008
Ulcerative colitis	contraindication	64766004	DOID:8577
Arterial thrombosis	contraindication	65198009
Drug AND/OR toxin-induced diarrhea	contraindication	65979008
Hypercalcemia	contraindication	66931009	DOID:12678
Ventricular fibrillation	contraindication	71908006
Hypercalciuria	contraindication	71938000
Arteriosclerotic vascular disease	contraindication	72092001
Hyperchloremia	contraindication	74450001
Spastic paralysis	contraindication	78403003
Disturbance of salivary secretion	contraindication	78948009
Third degree burn injury	contraindication	80247002
Chronic idiopathic constipation	contraindication	82934008
Oliguria	contraindication	83128009
Cor pulmonale	contraindication	83291003	DOID:8515
Hiatal hernia	contraindication	84089009	DOID:12642
Kidney disease	contraindication	90708001	DOID:557
Myasthenia gravis	contraindication	91637004	DOID:437
Kidney stone	contraindication	95570007
Gastrointestinal obstruction	contraindication	126765001
Autonomic dysreflexia	contraindication	129618003
Bleeding	contraindication	131148009
Partial atrioventricular block	contraindication	195039008
Acute pancreatitis	contraindication	197456007	DOID:2913
Myocardial dysfunction	contraindication	233928007
Disease of liver	contraindication	235856003	DOID:409
Hyporeninemic hypoaldosteronism	contraindication	236464008
Bladder outflow obstruction	contraindication	236645006
Pyloric obstruction	contraindication	244815007
Benign prostatic hyperplasia	contraindication	266569009
Retention of urine	contraindication	267064002
Drowsy	contraindication	271782001
Familial hyperkalemic periodic paralysis	contraindication	304737009	DOID:14451
Hypoxia	contraindication	389086002
Angle-closure glaucoma	contraindication	392291006	DOID:13550
Gastric ulcer	contraindication	397825006	DOID:10808
Respiratory insufficiency	contraindication	409623005
Chronic lung disease	contraindication	413839001
Disorder of coronary artery	contraindication	414024009
Hypertensive urgency	contraindication	443482000
Azotemia	contraindication	445009001
Severe dehydration	contraindication	450316000

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Exclusivity date	Description
3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML ;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML)	PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER	BAXTER HLTHCARE CORP	N207026	Jan. 13, 2015	RX	INJECTABLE	INJECTION	Jan. 13, 2022	AS A REPLACEMENT SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) AND IN CASE OF DRUG POISONING WHEN CRRT IS USED TO REMOVE DIALYZABLE SUBSTANCES
N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML)	PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER	BAXTER HLTHCARE CORP	N207026	Jan. 13, 2015	RX	INJECTABLE	INJECTION	Jan. 13, 2022	AS A REPLACEMENT SOLUTION IN CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) AND IN CASE OF DRUG POISONING WHEN CRRT IS USED TO REMOVE DIALYZABLE SUBSTANCES

Bioactivity Summary:

None

External reference:

ID	Source
4018085	VUID
N0000146424	NUI
4018085	VANDF
C0006686	UMLSCUI
CHEBI:3312	CHEBI
CHEMBL1200668	ChEMBL_ID
D002122	MESH_DESCRIPTOR_UI
DB01164	DRUGBANK_ID
M4I0D6VV5M	UNII
5284359	PUBCHEM_CID
1901	RXNORM
16	MMSL
4331	MMSL
d03799	MMSL
000774	NDDF
387377009	SNOMEDCT_US
68395000	SNOMEDCT_US
10035-04-8	SECONDARY_CAS_RN

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
BSS	HUMAN PRESCRIPTION DRUG LABEL	6	0065-0795	SOLUTION	0.48 mg	OPHTHALMIC	NDA	9 sections
BSS	HUMAN PRESCRIPTION DRUG LABEL	6	0065-0795	SOLUTION	0.48 mg	OPHTHALMIC	NDA	9 sections
BSS	HUMAN PRESCRIPTION DRUG LABEL	6	0065-1795	SOLUTION	0.48 mg	OPHTHALMIC	NDA	9 sections
HyperlyteCR	HUMAN PRESCRIPTION DRUG LABEL	5	0264-1943	INJECTION, SOLUTION, CONCENTRATE	0.37 g	INTRAVENOUS	UNAPPROVED DRUG OTHER	18 sections
HyperlyteCR	HUMAN PRESCRIPTION DRUG LABEL	5	0264-1943	INJECTION, SOLUTION, CONCENTRATE	0.37 g	INTRAVENOUS	UNAPPROVED DRUG OTHER	18 sections
Balanced Salt	HUMAN PRESCRIPTION DRUG LABEL	6	0264-1945	SOLUTION	0.48 mg	IRRIGATION	ANDA	11 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0264-2202	IRRIGANT	0.03 g	IRRIGATION	NDA	22 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0264-2202	IRRIGANT	0.03 g	IRRIGATION	NDA	22 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0264-2202	IRRIGANT	0.03 g	IRRIGATION	NDA	22 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0264-2202	IRRIGANT	0.03 g	IRRIGATION	NDA	22 sections
Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	4	0264-2203	IRRIGANT	0.02 g	IRRIGATION	NDA	18 sections
Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	4	0264-2203	IRRIGANT	0.02 g	IRRIGATION	NDA	18 sections
Balanced Salt	HUMAN PRESCRIPTION DRUG LABEL	6	0264-2514	SOLUTION	0.48 mg	IRRIGATION	ANDA	11 sections
Lactated Ringers Irrigation	HUMAN PRESCRIPTION DRUG LABEL	4	0264-7389	SOLUTION	20 mg	IRRIGATION	NDA	14 sections
Lactated Ringers Irrigation	HUMAN PRESCRIPTION DRUG LABEL	4	0264-7389	SOLUTION	20 mg	IRRIGATION	NDA	14 sections
Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	4	0264-7750	INJECTION, SOLUTION	0.02 g	INTRAVENOUS	NDA	23 sections
Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	4	0264-7750	INJECTION, SOLUTION	0.02 g	INTRAVENOUS	NDA	23 sections
Dextrose in Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	5	0264-7751	INJECTION, SOLUTION	0.02 g	INTRAVENOUS	NDA	22 sections
Dextrose in Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	5	0264-7751	INJECTION, SOLUTION	0.02 g	INTRAVENOUS	NDA	22 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0264-7780	INJECTION, SOLUTION	0.03 g	INTRAVENOUS	NDA	23 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0264-7780	INJECTION, SOLUTION	0.03 g	INTRAVENOUS	NDA	23 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0338-0104	IRRIGANT	33 mg	IRRIGATION	NDA	5 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0338-0104	IRRIGANT	33 mg	IRRIGATION	NDA	5 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0338-0105	INJECTION	0.33 g	INTRAVENOUS	NDA	16 sections
Ringers	HUMAN PRESCRIPTION DRUG LABEL	3	0338-0105	INJECTION	0.33 g	INTRAVENOUS	NDA	16 sections
Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	4	0338-0114	IRRIGANT	20 mg	IRRIGATION	NDA	5 sections
Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	4	0338-0114	IRRIGANT	20 mg	IRRIGATION	NDA	5 sections
Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	4	0338-0117	INJECTION, SOLUTION	20 mg	INTRAVENOUS	NDA	19 sections
Lactated Ringers	HUMAN PRESCRIPTION DRUG LABEL	4	0338-0117	INJECTION, SOLUTION	20 mg	INTRAVENOUS	NDA	19 sections
Lactated Ringers and Dextrose	HUMAN PRESCRIPTION DRUG LABEL	5	0338-0125	INJECTION, SOLUTION	20 mg	INTRAVENOUS	NDA	18 sections